Metronidazole
Nitroimidazole antiprotozoal and antibacterial in USP/EP/BP/IP grade for oral tablet, IV injectable, and topical formulation manufacturing. Sourced for amoebiasis, giardiasis, and anaerobic infection product lines.
Pharmaceutical & Life Science Solutions
Nitroimidazole and thiazolide APIs targeting anaerobic protozoan infections. Supplied in USP/EP/BP grade for oral tablet, suspension, and microgranule formulation manufacturing across global GI/parasitology product lines.
Nitroimidazole antiprotozoal and antibacterial in USP/EP/BP/IP grade for oral tablet, IV injectable, and topical formulation manufacturing. Sourced for amoebiasis, giardiasis, and anaerobic infection product lines.
Thiazolide antiparasitic in USP/EP grade for oral tablet and suspension formulation manufacturing. Sourced for cryptosporidiosis and giardiasis treatment product lines.
Nitroimidazole derivative in BP/EP/USP grade for oral tablet formulation manufacturing. Sourced for amoebiasis, giardiasis, and trichomoniasis treatment product lines across EU and Asian export markets.
Long-acting nitroimidazole in BP/EP/USP grade for single-dose oral microgranule and tablet formulation manufacturing. Sourced for trichomoniasis and giardiasis treatment product lines.
Second-generation nitroimidazole in USP/EP grade for oral tablet formulation manufacturing. Sourced for giardiasis, trichomoniasis, and amoebiasis single-dose treatment product lines.